Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipramine for multi-organ bodily distress syndrome
2011-004294-87Phase 2Completed
- Sponsor
- Per Klausen Fink
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bodily distress syndrome (BDS), somatic symptom disorder (SSD) and Functional disorder comparing Imipramine with Placebo (2 arms). Primary endpoint: Clinical Global Improvement Scale. Started Oct 2011; status: completed.
02
Drugs
imipramine
03
Conditions
bodily distress syndrome (BDS)somatic symptom disorder (SSD)Functional disorder
Beyond the preview
Go deeper on 2011-004294-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004294-87.